Hypertension and the kidney: Culprit and victim

Nephrology Dialysis Transplantation

Volumn 11, Issue 10, 1996, Pages 1961-1966

  Koomans, Hein A ^a   Joles, Jaap A ^a   Rabelink, Ton J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; HYPERTENSION; KIDNEY ARTERY STENOSIS; KIDNEY FUNCTION; PRIORITY JOURNAL; RENAL ARTERY; REVIEW; SODIUM RETENTION; VASOCONSTRICTION; ANIMAL; KIDNEY; KIDNEY CIRCULATION; NATRIURESIS; PATHOPHYSIOLOGY; RENOVASCULAR HYPERTENSION;

ANIMALS; HUMANS; HYPERTENSION; HYPERTENSION, RENOVASCULAR; KIDNEY; NATRIURESIS; RENAL CIRCULATION; VASOCONSTRICTION;

EID: 0029857037     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a027080     Document Type: Review

References (110)

1. Winnearls CG, Ledingham JGG. Prof. A.E.G. Raine, 1945-1995. An appreciation. Nephrol Dial Transplant 1996; 11: 4-5
2. Goldblatt H. Experimental renal hypertension. Mechanism of production and maintenance. Circulation 1958; 17: 642-647
3. Guyton AC, Coleman TG. Quantitative analysis of the pathophysiology of hypertension. Circ Res 1969; 24 [Suppl. I]: 11-114
4. Guyton AC. Kidneys and fluids in pressure regulation. Small volume but large pressure changes. Hypertension 1992; 19 [Suppl. I]: 12-118
5. Lifton RP. Genetic factors in hypertension. Curr Opin Nephrol Hypertens 1993; 2: 258-264
6. Morris BJ. Identification of essential hypertension genes. J Hypertens 1993; 11: 115-120
7. Cusi D, Bianchi G. Renal mechanisms of genetic hypertension: from the molecular level to the intact organism. Kidney Int 1996; 49: 1754-1759
8. Kaplan NM. Dietary salt intake and blood pressure. J Am Med Assoc 1984; 251: 1429-1430
9. Elliot P. Observational studies of salt and blood pressure. Hypertension 1991; 17 [Suppl. I]: 13-18
10. Volhard F, Fahr T. Die Brightsche Nierenkrankheit. Klinik, Pathologie und Atlas. Berlin: Springer; 1914: 225-239
11. Dahl LK, Heine M. Primary role of renal homografts in setting chronic blood pressure levels in rats. Circ Res 1975; 36: 692-696
12. Rettig R, Folberth C, Stauss H, Kopf D, Waldherr R, Unger T. Role of the kidney in primary hypertension: a renal transplantation study in rats. Am J Physiol 1990; 258: F606-F611
13. Curtis JJ, Luke RG, Dustan HP, Kashgarian M, Whelchel JD, Jones P, Diethelm AG. Remission of essential hypertension after renal transplantation. N Engl J Med 1983; 309: 1009-1015
14. Van Hooft IMS, Grobbee DE, Derkx FHM. De Leeuw PW, Schalekamp MADH, Hofman A. Renal hemodynamics and the renin-angiotensin aldosterone system in normotensive subjects with hypertensive and normotensive parents. N Engl J Med 1991; 324: 1305-1311
15. Selkurt EE. Effect of pulse pressure and mean arterial pressure modification on renal hemodynamics and electrolyte excretion. Circulation 1951; 4: 541-551
16. Guyton AC Coleman TG, Cowley AV Jr, Scheel KW, Manning RD Jr, Norman RA Jr. Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension. Am J Med 1972; 52: 584-594
17. Brod J. Essential hypertension. Haemodynamic observations with a bearing on its pathogenesis. Lancet 1960; II: 773-778
18. Brown JJ, Lever AF, Robertson JIS, Schalekamp MA. Renal abnormality of essential hypertension. Lancet 1974; II: 320-323
19. London GM, Safar ME. Renal haemodynamics, sodium balance and the capacitance system in essential hypertension. Clin Sci 1988; 74: 449-453
20. Cogan MG. Angiotensin II: a powerful controller of sodium transport in the early proximal tubule. Hypertension 1990; 15: 451-458
21. Denton KM, Fennessy PA, Alcorn D, Anderson WP. Morphometric analysis of the actions of angiotensin II on renal arterioles. Am J Physiol 1992; 262: F367-F372
22. Williams GH, Hollenberg NK. Non-modulating hypertension. A subset of sodium-sensitive hypertension. Hypertension 1991; [Suppl. I]: 181-185
23. Dluhy RG, Smith K, Taylor T, Hollenberg NK, Williams GH. Prolonged converting enzyme inhibition in non-modulating hypertension. Hypertension 1998; 13: 371-377
24. Sealey JE, Blumenfeld JD, Bell GM, Pecker MS, Sommers SC, Laragh JH. On the renal basis for essential hypertension: nephron heterogeneity with discordant renin secretion causing hypertensive vasoconstriction-volume relationship. J Hypertens 1988; 6: 763-777
25. Mitchell KD, Braam B, Navar LG. Hypertensinogenic mechanisms mediated by renal actions of renin-angiotensin system. Hypertension 1992; 19: 118-127
26. Westenend PJ, Nooyen YA, Van Brummelen P. Weening JJ. Vasodilation protects Wistar Kyoto rats from progressive glomerulosclerosis after uninephrectomy. J Clin Lab Med 1991; 177: 25-32
27. Roberts JM, Redman CWG. Pre-eclampsia: more than pregnancy-induced hypertension? Lancet 1993; 341: 1447-1451
28. Raine AE, Bedford L, Simpson AW, Ashley CC, Brown R, Woodhead JS, Ledingham JG. Hyperparathyroidism, platelet intracellular free calcium and hypertension in chronic renal failure. Kidney Int 1993; 43: 700-705
29. Aksamit TR, Floras JS, Victor RG, Aylward PE. Paroxysmal hypertension due to sinoaortic baroreceptor denervation in humans. Hypertension 1987; 9: 309-314
30. Deray G, Benhmida M, Hoang PL, Maksud P, Aupetit B, Baumelou A, Jacobs C. Renal function and blood pressure in patients receiving long-term low-dose cyclosporine therapy for idiopathic autoimmune uveitis. Ann Intern Med 1992; 117: 578-583
31. Roger SD, Baker LR, Raine AE. Autonomic dysfunction and the development of hypertension in patients treated with recombinant human erythropoietine. Clin Nephrol 1993; 39: 103-110
32. Hollenberg NK, Williams GH, Burger B, Chenitz W. Hoosmand I, Adams DF. Renal blood flow and its response to angiotensin II. An Interaction between oral contraceptive agents, sodium intake, and the renin-angiotensin system in healthy young women. Circ Res 1976; 38: 35-40
33. Bravo E, Fouad-Tarazi F, Rossi G, Imamura M, Lin WW, Madkour MA, Wicker P, Cressman MD, Saragoca M. A reevaluation of the hemodynamics of pheochromocytoma. Hypertension 1990; 15 [Suppl. I]: I128-I131
34. Koomans HA, Roos JC, Dorhout Mees EJ. Sodium balance in renal failure. A comparison of patients with normal subjects under extremes of sodium intake. Hypertension 1985; 7: 714-721
35. Ritz E, Koomans HA. New insights into mechanisms of blood pressure regulation in uremic patients. Nephrol Dial Transplant 1996; 11 [Suppl. 2]: 52-59
36. First MR, Neylan JF, Rocher LL, Tejani A. Hypertension after renal transplantation. J Am Soc Nephrol 1994; 4 [Suppl. I]: S30-S36
37. Raine AE. Does Antihypertensive therapy modify chronic allograft failure? Kidney Int 1995; 52 [Suppl.]: S107-S111
38. Gordon RD, Ziesak MD, Tunny TJ, Stowasser M, Klemm SA. Evidence that primary aldosteronism may not be uncommon - twelve percent incidence among antihypertensive drug trial volumteers. Clin Exp Pharmacol Physiol 1993; 20: 296-298
39. Boer WH, Koomans HA, Dorhout Mees EJ. Lithium clearance in mineralocorticoid escape in humans. Am J Physiol 1987; 252: F382-F386
40. Gaillard CA, Koomans HA, Rabelink TJ, Braam B, Boer P, Dorhout Mees EJ. Enhanced natriuretic effect of atrial natriuretic factor during mineralocorticoid escape in man. Hypertension 1988; 12: 450-456
41. Katholi RE, Whitlow PL, Winternitz SR, Oparil S. Importance of the renal nerves in established two-kidney, one clip Goldblatt hypertension. Hypertension 1982; 4 [Suppl. II]: II166-II174
42. Faber JE, Brody MJ. Afferent renal nerve-dependent hypertension following acute renal artery stenosis in the conscious rat. Circ Res 1985; 57: 676-688
43. Levine GN, Keaney JF, Vita JA. Cholesterol reduction in cardiovascular disease. N Engl J Med 1995; 332: 512-521
44. Lüscher TF, Boulanger CM, Yang Z, Noll G, Dohi Y. Interactions between endothelium-derived relaxing and contracting factors in health and cardiovascular disease. Circulation 1993; 87 [Suppl. V]: V36-V44
45. Chen PY, Sanders PW. L-arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J Clin Invest 1991; 88: 1559-1567
46. Lüscher TF, VanHoutte PM. Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension 1986; 8: 344-348
47. Zhang BL, Liu KL, Benzoni D, Sassard J. Nitric oxide and eicosanoid interactions in kidneys of Lyon hypertensive rats. J Hypertens 1993; 5 [Suppl.]: 136-137
48. Tracy RE, Newman WP, Wattingey WA, Srinivasan SR, Strong JP, Berenson GS. Histologic features of atherosclerosis and hypertension from autopsies of young individuals in a defined geographic population. The Bogalusa Heart Study. Atherosclerosis 1995; 116: 163-179
49. Tracy RE, Strong JP, Newman WP, Malcom GT, Oalmann MC, Guzman MA. Renovasculopathies of nephrosclerosis in relation to atherosclerosis at ages 25 to 54 years. Kidney Int 1996; 49: 564-570
50. Agodoa LY, Eggers PW. Renal replacement therapy in the United States: data from the United States Renal Data System. Am J Kidney Dis 1995; 25: 119-133
51. Valderrabano F, Jones EHP, Mallick NP. Report on management of renal failure in Europe, XXIV, 1993. Nenhrol Dial Transplant 1995; 10 [Suppl. 5]: 1-25
52. Levy SB, Talner LB, Coel MN, Holle R, Stone RA. Renal vasculature in essential hypertension: racial differences. Ann Intern Med 1978; 88: 12-16
53. Tracy R, Bhandaru SY, Oalmann MC, Guzman MA, Newmann WP. Blood pressure and nephrosclerosis in black and white man and women aged 25 to 54. Mod Pathol 1991; 4: 602-608
54. Raine AE. Hypertension and the kidney. Br Med Bull 1994; 50: 322-341
55. Feld LG, Van Liew JB, Brentjens JR, Boylan JW. Renal lesions and proteinuria in the spontaneously hypertensive rat made normotensive by treatment. Kidney Int 1981; 20: 606-614
56. Raij L. Azar S, Keane WF. Role of hypertension in progressive immune injury. Hypertension 1985; 7: 398-404
57. Tolins JP, Stone BG, Raij L. Interactions of hypercholesterolemia and hypertension in initiation of glomerular injury. Kidney Int 1992; 41: 1254-1261
58. Bank N, Alterman L, Aynedjian. Selective deep nephron hyperfiltration in uninephrectomized spontaneously hypertensive rats. Kidney Int 1983; 24: 185-191
59. Brazy PC, Stead WW, Fitzwilliam JF. Progression of renal insufficiency: role of blood pressure. Kidney Int 1989; 35: 670-674
60. Perneger TV, Nieto FJ, Whelton PK, Klag MJ, Comstock GW, Szklo M. A prospective study of blood pressure and serum creatinine. J Am Med Assoc 1993; 269: 488-493
61. Maschio G, Alberti D, Janin G, Locatelli F, Mann JFE, Motolese M, Ponticelli C, Ritz E, Zuchelli P, and the angiotensin-converting-enzyme inhibition in progressive renal insufficiency study group. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. M Engl J Med 1996; 334: 939-945
62. Noll G, Wenzel RR, Schneider M, Oesch V, Binggeli C. Shaw S, Weidmann P, Lüscher TF. Increased activation of sympathetic nervous system and endothelin by mental stress in normotensive offspring of hypertensive parents. Circulation 1996; 93: 866-869
63. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-808
64. Walder CE, Thiemermann C, Vane JR. The involvement of endothelium-derived relaxing factor in the regulation of renal cortical blood flow in the rat. Br J Pharmacol 1991; 102: 967-973
65. G-nitro-L-arginine methyl ester on renal function and blood pressure. Am J Physiol 1991; 261: F1033-F1037
66. Bech JN, Nielsen CB, Pedersen EB. Effects of systemic NO synthesis inhibition on RPF, GFR, UNa and vasoactive hormones in healthy humans. Am J Physiol 1996; 270: F845-F851
67. Baylis C, Mitruka B, Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest 1992; 90: 278-281
68. Ribeiro MO, Antunes E, De Nucci G, Lovisolo SM, Zatz R. Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension. Hypertension 1992; 20: 298-303
69. Ono H, Ono Y, Frohlich ED. Nitric oxide synthase inhibition in spontaneously hypertensive rats: systemic renal, and glomerular hemodynamics. Hypertension 1995; 26: 249-255
70. Raij L. Glomerular thrombosis in pregnancy: role of L-arginine and nitric oxide pathway. Kidney Int 1994; 45: 775-781
71. Remuzzi G, Ruggenenti P. The hemolytic uremic syndrome. Kidney Int 1995; 47: 2-19
72. Kon V, Sugiura M, Inagami T, Harvie BR, Ichikawa I, Hoover RL. Role of endothelin in cyclosporin-induced glomerular dysfunction. Kidney Int 1990; 37: 1487-1491
73. Diederich D, Yang Z, Lüscher TF. Chronic cyclosporin therapy impairs endothelium-dependent relaxation in the renal artery of the rat. J Am Soc Nephrol 1992; 2: 1291-1297
74. Kaasjager HAH, Koomans HA, Rabelink TJ. Efectiveness of enalapril versus nifedipine to antagonize blood pressure and renal response to endothelin in humans. Hypertension 1995; 25: 620-625
75. Treasure CB, Klein L, Weintraub WS, Talley JD, Stillabower ME, Kosinski AS, Zhang J, Boccuzzi SJ, Cedarholm JC, Alexander RW. Beneficial effects of cholesterol lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 1995; 332: 481-487
76. Stroes ESG, Koomans HA, De Bruin TWA, Rabelink TJ. Short-term deterioration and improvement in vascular function in the forearm of hypercholesterolaemic patients off and on lipid lowering therapy. Lancet 1995; 346: 467-471
77. Kiowski W, Linder L, Stoschitzky K, Pfisterer M, Burckhardt D, Burkart F, Buhler FR. Diminished vascular response to inhibition of endothelium-derived nitric oxide and enhanced vasoconstriction to exogenously administered endothelin-1 in clinically healthy smokers. Circulation 1994; 90: 27-34
78. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes. Circulation 1993; 88: 2510-2516
79. Mänttäri M, Tiula E, Manninen V. Effects of hypertension and dyslipidemia on the decline in renal function. Hypertension 1995; 26: 670-675
80. Massy ZA, Kasiske BL. Hyperlipidemia and its management in renal disease. Curr Opinion Nephrol Hyper tens 1996; 5: 141-146
81. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986
82. Pedrinelli R, Gampietro O, Carmassi F, Melillo E, Dell'Omo G, Catapano G, Matteucci E, Talatico L, Morale M, De Negri F, Di Bello V. Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet 1994; 344: 14-18
83. Blann AD, Dobrotova M, Kubisz P, McCollum CN. Von Willebrand Factor, soluble P-selectin, tPA and PAI in atherosclerosis. Thromb Haemost 1995; 74 [2]: 626-630
84. Lüscher TF. The endothelium in hypertension: bystander, target or mediator? J Hypertension 1994; 12: S105-S117
85. Bigazzi R, Bianchi S, Campese VM, Baldari G. Prevalence of microalbuminuria is a large population of patients with mild to moderate essential hypertension. Nephron 1992; 61: 94-97
86. Hörner D, Fliser D, Klimm HP, Ritz E. Albuminuria in normotensive and hypertensive individuals attending offices of general practionars. J Hypertens 1996; 14: 655-660
87. Hansen KJ. Prevalence of ischemic nephropathy in the atherosclerotic population. Am J Kidney Dis 1994; 24: 615-621
88. Greco BA, Breyer JA. The natural history of renal artery stenosis: who should be evaluated for suspected ischemic nephropathy? Semin Nephrol 1996; 16: 2-11
89. Piccoli G, Salomone M, Quarello F, Piccoli GB, Verzetti G. Ramello A, Magistroni P. Regional registry of dialysis and transplantation of Piedmont, Italy. Nephrol Dial Transplant 1995; 10: 444-447
90. Sytkowski PA, Kannel WB, D'Agostino RB. Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study. N Engl J Med 1990; 322: 1634-1641
91. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. JNC V. Arch Intern Med 1993; 153: 154-183
92. Scoble JE, Maher ER, Hamilton G, Dick R, Sweny P, Moorhead JF. Atherosclerotic renovascular disease causing impairment: a case for treatment. Clin Nephrol 1989; 31: 119-122
93. Appel RG, Bleyler AJ, Reavis S, Hansen KJ. Renovascular disease in older patients beginning renal replacement therapy. Kidney Int 1995; 48: 171-176
94. Schwartz CJ, White TA. Stenosis of the renal artery: an unselected necropsy study. Br Med J 1964; 2: 1415-1421
95. Holley KE, Hunt JC, Brown AL, Kincaid OW, Sheps SG. Renal artery stenosis: a clinical-pathologic study in normotensive and hypertensive patients. Am J Med 1964; 37: 14-22
96. Choudhri AH, Cleland JGF, Rowlands PC, Tran TL, McCarty M, Al-Ktoubi MAO. Unsuspected renal aretry stenosis in peripheral vascular disease. Br Med J 1990; 301: 1197-1198
97. Olin JW, Melia M, Young JR, Graor RA, Risius B. Prevalence of atherosclerotic renal artery stenosis in patients with atherosclerosis elsewhere. Am J Med 1990; 88: 46-51
98. Harding MB, Smith LR, Himmelstein SI, Harrison K, Phillips HR, Schwab SJ, Hermiller JB, Davidson CJ, Bashore TM. Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catherization. J Am Soc Nephrol 1992; 2: 1608-1616
99. Dean RH, Kieffer RW, Smith BM, Oates JA, Nadeau JHJ, Hollifield JW, Dupont WD. Renovascular hypertension: anatomic and renal function changes during drug therapy. Arch Surg 1981; 116: 1408-1415
100. Schreiber MJ, Pohl MA, Novick AC. The natural history of atherosclerotic and fibrous renal artery disease. Urol Clin North Am 1984: 11: 383-392
101. Guzman RP, Zierler RE, Isaacson JA, Bergelin RO, Strandness E. Renal atrophy and arterial stenosis. A prospective study with duplex ultrasound. Hypertension 1994; 23: 346-350
102. Hansen KJ, Starr SM, Sands E, Burkart JM, Plonk GW, Dean RH. Contemporary surgical management of renovascular disease. J Vasc Surg 1992; 16: 319-313
103. Novick AC. Options for therapy of ischemic nephropathy: role of angioplasty and surgery. Am J Kidney Dis 1996; 16: 53-60
104. Sos TA, Pickering TG, Sniderman K, Saddekni S, Case DB, Silane MF, Vaughan ED, Laragh JH. Percutaneous transluminal renal angioplasty in renovascular hypertension due to atheroma or fibromuscular dysplasia. N Engl J Med 1983; 309: 274-279
105. Canzanello VJ, Millan VG, Spiegel JE, Ponce P, Kopelman RI, Madias NE. Percutaneous transluminal renal angioplasty in management of renovascular hypertension: results in 100 patients. Hypertension 1989; 13: 163-172
106. Weibull H, Bergqvist D, Bergentz SE, Jonsson K, Hulthén L, Manhem P. Percutaneous transluminal angioplasty vs surgical reconstruction of atherosclerotic renal artery stenosis: a prospective study. J Vasc Surg 1993; 18: 841-852
107. Macleod M, Taylor AD, Baxter G, Harden P, Briggs D, Moss J, Semple PF, Connell JMC, Dominiczak AF. Renal artery stenosis managed by Palmaz stent insertion: technical and clinical outcome. J Hypertens 1995; 13: 1791-1795
108. Van de Yen PGJ, Beutler JJ, Kaatee R, Beek FJ, Geyskes GG. Mali WPThM, Koomans HA. Transluminal vascular stent for ostial atherosclerotic renal artery stenosis. Lancet 1995; 346: 672-674
109. Missouris CG, Allen CM, Baien FG, Buckenham T, Lees WR, MacGregor GA. Non-invasive screening for renal artery stenosis with ultrasound contrast enhancement. J Hypertens 1996; 14: 519-524
110. Olbricht CJ, Paul K, Prokop M, Chanvan A, Schaefer-Prokop CM, Jandeleit K, Koch KM, Galanski M. Minimally invasive diagnosis of renal artery stenosis by spiral computed tomography angiography. Kidney Int 1995; 48: 1332-1337